GlassScriptPhysician profile
Anna C Pavlides
NPI 1508805904
$915.41
in general payments reported to CMS, 2019-2025
15 companies · $18.87 in 2025
The $18.87 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $49.34 · 2021: $290 · 2022: $16.85 · 2023: $80.67 · 2024: $137 · 2025: $18.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $365.21 | 2019-2025 | Slynd |
| Abbvie INC. | $121.69 | 2019-2021 | |
| Allergan, INC. | $70.33 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.26 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $43.60 | 2019-2021 | |
| Avion Pharmaceuticals | $43.40 | 2019-2020 | |
| Amgen INC. | $41.58 | 2019 | |
| Duchesnay USA Incorporated | $34.48 | 2019 | |
| Evofem Biosciences, INC. | $31.20 | 2021 | |
| Lupin INC. | $24.00 | 2019 | |
| Organon LLC | $22.64 | 2024 | |
| Pfizer INC. | $19.63 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.37 | 2019 | |
| Hologic Sales and Service, LLC | $17.46 | 2019 | |
| Mission Pharmacal Company | $15.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Pavlides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.